Practical Patient Care Weekly
Practical Patient Care
Your one stop, leading multi-platform news source for the global healthcare sector.
Welcome to another edition of the Practical Patient Care newsletter!
Discover the latest insights and analyses from the global healthcare market over the past week, brought to you by Practical Patient Care
bioMérieux ! recently announced, the BIOFIRE? SPOTFIRE? Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. FDA Special 510(k) clearance and CLIA-waiver.
This innovative multiplex PCR test detects 5 common viral and bacterial causes of respiratory or sore throat infections in about 15 minutes, bringing fast and actionable results directly to the point of care.
Dr. Chuck Cooper, our Executive Vice-President and Chief Medical Officer, highlighted, "This represents a step forward in healthcare, ultimately increasing diagnostic yield and removing the need to reflex to culture in most patients."
Jennifer Zinn, Executive Vice President, Clinical Operations, added, "Our offer meets the current needs of the growing decentralized, POC market, bringing syndromic testing to the frontline of patient care."
Quest Diagnostics and Allina Health have announced a significant partnership that will reshape laboratory services in Minnesota and western Wisconsin.
Quest Diagnostics has entered into a definitive agreement to acquire select laboratory assets from Allina Health, aiming to enhance access to innovative and cost-effective diagnostic services in the region.
This strategic move will allow Quest to expand its extensive service offerings throughout Minnesota and western Wisconsin, providing broader access to their innovative laboratory services for providers and patients.
The transaction is expected to be completed in the third quarter of 2024, subject to customary regulatory reviews.Jim Davis, Chairman, CEO and President of Quest Diagnostics, emphasized the shared commitment of both organizations to deliver quality and innovative laboratory services at affordable prices.?
He stated, "This transaction also reflects progress in delivering on our strategy, which includes generating growth through accretive laboratory acquisitions."Dominica Tallarico,B.S., M.S.,FACHE, Chief Operations Officer for Allina Health, expressed confidence in Quest as the right partner to build upon Allina's foundation of excellence in lab services.?
She highlighted that this move will allow Allina Health to reinvest its non-profit resources to support its caring mission well into the future.
This partnership represents a significant development in the healthcare landscape of the region.
Apollo Cancer Centres and Accuray have joined forces to launch India's first Robotic and Stereotactic Radiotherapy Program.
This ground-breaking initiative will establish education centres in Chennai and Bangalore, offering advanced training to oncology professionals across the subcontinent.
Dinesh Madhavan, President of Apollo Hospital Enterprises, states: "The inception of the Robotic Stereotactic Radiotherapy Program by Apollo Cancer Centres and Accuray will advance training facilities for the ASEAN region."
领英推荐
This collaboration introduces Accuray's cutting-edge CyberKnife S7 System, revolutionizing precision cancer treatment.
NOUL Co., Ltd. , an On-Device AI healthcare company, is collaborating with the Centers for Disease Control and Prevention and Kenya Medical Research Institute (KEMRI) on a ground-breaking project.
Their digital microscopy-based solution, miLab? MAL, will be field-tested on 2,000 patients in western Kenya.
This AI-powered technology aims to revolutionize malaria diagnosis, addressing challenges with current methods and potentially improving healthcare outcomes in endemic areas.
A significant step towards more accurate and efficient malaria detection!
Accuray has partnered with TrueNorth Medical Physics to enhance radiation oncology support and advance cancer care for more patients.
This collaboration will see TrueNorth offering complementary and supplementary services to those provided by Accuray, functioning as an extension of hospital teams.
TrueNorth’s managing partner, Matt D., highlighted their extensive experience with Accuray’s Radixact, TomoTherapy, and CyberKnife platforms, stating, “Our organization is dedicated to providing unbiased feedback and support that improves the practice of radiation therapy medicine.”
Accuray’s President and CEO, Suzanne Winter, emphasized, “We partnered with TrueNorth Medical Physics to provide care teams with another option for obtaining the resources they require to advance the treatment of cancer for more patients within their facilities.”
This partnership aims to address staffing challenges and ensure that radiation oncology departments have the necessary support to achieve their patient treatment goals.
To have a story featured on next week's newsletter, or require press and marketing support you can contact our team directly...
Editorial Enquiries - [email protected]
Press & Marketing support - [email protected]
Thanks for reading; we hope you enjoyed it.
Until next week.